細胞増殖/細胞毒性測定試薬の基礎から実際に使用する試薬の原理、また測定指標までご説明いたします。

また、細胞の状態を理解する上で重要な、細胞内代謝とミトコンドリア解析に関しても小社製品を絡めてご説明いたします。

これから実験を始められる方におススメの内容となっておりますので是非ご参加ください。

【演者：Crown Bioscience, Inc. Xiaoxi Xu, Senior Director of Molecular and Cellular Biology】

《要旨》

For preclinical phase of cancer drug development, cell culture is an important and necessary process. While 2D cell lines are contributing a lot to the drug efficacy profiling and MOA researches, more and more 3D methods are developed to better mimic the in vivo microenvironment. To improve the translational successful rate from in vitro to in vivo, it is well acknowledged that using patient-derived material will greatly increase the rate and bridge the gap between 2D cell lines and in vivo animals/clinical patients. With the organoid culture technique, Crown will present you with a variety of the in vitro model system and the applications with advantages or disadvantages in meeting the study goals. We have cell lines, primary tumor cells, organoids in both 2D and 3D culture formats in service. And we will show how you can choose for your cancer drug development.